RxDoctor Payments DataLook up a doctor →

Siddharth Padia, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1952578254

Payments from drug & device makers

$1,559,955in general payments, 2019–2025

Across 769 payments — averaging $2028.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$877K
  • Siemens Medical Solutions USA, Inc.$270K
  • Delcath Systems$211K
  • Biocompatibles UK Ltd$42K
  • Biocompatibles, Inc.$40K
  • Merit Medical Systems Inc$27K
  • plus $91K from 27 others

What the payments were for

  • Consulting fees$424,04144%
  • Speaking & faculty fees$412,03843%
  • Grants$5000%
  • Travel & lodging$91,47710%
  • Food & beverage$30,8023%
  • Education$1,6220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,559,955 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$145,849
Medicare patients
182
Services billed
1,427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone20$106
Naproxen13$27

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →